Combination Therapy by Tissue-Specific Suicide Gene and Bevacizumab in Intramedullary Spinal Cord Tumor

PURPOSE: Malignant gliomas are aggressive spinal cord tumors. In this study, we hypothesized that combination therapy using an anti-angiogenic agent, bevacizumab, and hypoxia-inducible glioblastoma-specific suicide gene could reduce tumor growth. MATERIALS AND METHODS: In the present study, we evalu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Yonsei Med J
Päätekijät: Gwak, So-Jung, Che, Lihua, Yun, Yeomin, Lee, Minhyung, Ha, Yoon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Yonsei University College of Medicine 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7700877/
https://ncbi.nlm.nih.gov/pubmed/33251778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2020.61.12.1042
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia